Bayer Schering Pharma Receives SFDA Approval for MS Drug

Bookmark and Share

GEN -- Chinese regulatory authorities approved Bayer Schering Pharma’s interferon beta-1b, Betaferon®, as a treatment for relapsing-remitting multiple sclerosis (MS). Bayer says it plans to launch the drug in the country by mid-2010.
MORE ON THIS TOPIC